Annual report pursuant to Section 13 and 15(d)

Segment Reporting - Summary of Net Revenue, Cost of Sales, Depreciation and Amortization, Operating Profit, Interest Expense, Income Tax (Expense) Benefit and Assets by Segment (Detail)

v3.10.0.1
Segment Reporting - Summary of Net Revenue, Cost of Sales, Depreciation and Amortization, Operating Profit, Interest Expense, Income Tax (Expense) Benefit and Assets by Segment (Detail) - USD ($)
 12 Months Ended
Nov. 30, 2018
Nov. 30, 2017
Segment Reporting Information [Line Items]    
Total net revenue $ 29,218,490 $ 25,384,279
Total cost of sales 8,539,662 6,724,391
Total operating profit 5,189,303 5,006,226
Total interest expense 1,546,900 1,302,650
Total depreciation and amortization 180,264 131,614
Total income tax (expense) benefit (4,472,504) (1,308,603)
Total other comprehensive income (loss) 300,119 6,457
Total assets 42,390,143 23,909,997
Umbilical Cord Blood and Cord Tissue Stem Cell Service [Member]    
Segment Reporting Information [Line Items]    
Total net revenue 28,817,872 24,942,089
Total cost of sales 7,744,208 6,257,628
Total operating profit 5,620,394 5,067,228
Total interest expense 1,546,900 1,302,650
Total income tax (expense) benefit (4,472,504) (1,308,603)
Total other comprehensive income (loss) 300,119 6,457
PrepaCyte CB [Member]    
Segment Reporting Information [Line Items]    
Total net revenue 104,323 442,190
Total cost of sales 169,397 466,763
Total operating profit (101,329) (61,002)
Public Cord Blood Banking [Member]    
Segment Reporting Information [Line Items]    
Total net revenue 296,295  
Total cost of sales 626,057  
Total operating profit (329,762)  
Operating Segments [Member]    
Segment Reporting Information [Line Items]    
Total depreciation and amortization 317,326 229,995
Operating Segments [Member] | Umbilical Cord Blood and Cord Tissue Stem Cell Service [Member]    
Segment Reporting Information [Line Items]    
Total depreciation and amortization 281,072 193,741
Operating Segments [Member] | PrepaCyte CB [Member]    
Segment Reporting Information [Line Items]    
Total depreciation and amortization 36,254 36,254
Umbilical Cord Blood and Cord Tissue Stem Cell Service [Member]    
Segment Reporting Information [Line Items]    
Total assets 26,239,260 23,360,714
PrepaCyte CB [Member]    
Segment Reporting Information [Line Items]    
Total assets 319,802 $ 549,283
Public Cord Blood Banking [Member]    
Segment Reporting Information [Line Items]    
Total assets $ 15,831,081